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Abstract
Objectives—To examine the relationships among patient characteristics, labor inputs, and
improvement in glycosylated hemoglobin (A1C) level in a successful primary care–based diabetes
disease management program (DDMP).
Study Design—We performed subanalyses to examine the relationships among patient
characteristics, labor inputs, and improvement in A1C level within a randomized controlled trial.
Control patients received usual care, while intervention patients received usual care plus a
comprehensive DDMP.
Methods—The primary outcome was improvement in A1C level over 12 months stratified by
intervention status and patient characteristics. Process outcomes included the number of actions or
contacts with patients, time spent with patients, and number of glucose medication titrations or
additions.
Results—One hundred ninety-three of 217 enrolled patients (88.9%) had complete 12-month
follow-up data. Patients in the intervention group had significantly greater improvement in A1C
level than the control group (−2.1% vs −1.2%, P = .007). In multivariate analysis, no significant
differences were observed in improvement in A1C level when stratified by age, race/ethnicity,
income, or insurance status, and no interaction effect was observed between any covariate and
intervention status. Among intervention patients, we observed similar labor inputs regardless of
age, race/ethnicity, sex, education, or whether goal A1C level was achieved.
Conclusions—Among intervention patients in a successful DDMP, improvement in A1C level
was achieved regardless of age, race/ethnicity, sex, income, education, or insurance status. Labor
inputs were similar regardless of age, race/ethnicity, sex, or education and may reflect the
nondiscriminatory nature of providing algorithm-based disease management care.
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More than 20 years ago, the US Department of Health and Human Services issued their
Report of the Secretary’s Task Force on Black and Minority Health.1 This study
documented many health disparities and sparked efforts to improve the health and healthcare
of vulnerable populations and to raise awareness and concern for health disparities research.
2–4 Disparate trends in care across various groups have been noted, including racial/ethnic
minorities, as well as women, children, older adults, and other potentially vulnerable
populations. Despite this research and advocacy, health disparities persist across a wide
spectrum of disease processes, clinical settings, and populations within the United States.
According to the 2007 National Healthcare Disparities Report,5 some disparate trends are
improving, such as rates of cholesterol control among racial/ethnic minorities; however,
many are in major need of improvement, particularly in the areas of diabetes care and
chronic disease management.
The Agency for Healthcare Research and Quality (AHRQ) has identified several priority
groups that serve as targets for health disparities research and quality improvement. These
groups include racial/ethnic minorities, persons with low incomes, women, children, older
adults, those with disabilities, and rural inhabitants.5,6 In general, members of these priority
groups along with those who have less education and no private insurance are more likely to
receive poorer quality of care and to experience greater barriers in terms of access to care
compared with their respective counterparts.5 For example, compared with white patients,7
Hispanic and lower-income patients with diabetes mellitus are less likely to receive the
recommended services for diabetes care such as timely measurement of lipid levels and
glycosylated hemoglobin (A1C) levels, and black patients have higher rates of many of the
complications of diabetes such as admissions for lower extremity amputations.8 Although
studies performed by Trivedi et al9 and by Chin et al10 have demonstrated that quality
improvement measures can lead to reduced disparities in some diabetes-related processes of
care, it has been more difficult to influence outcome measures such as attainment of goal
blood glucose control (as measured by A1C level).11 Findings from recent studies9,12 have
also suggested that disparities in diabetes care may be related to patient characteristics,
provider characteristics, or system-level factors.
Disease management programs have been shown to be successful in improving care for
patients with diabetes,13–17 and there is growing interest in the usefulness of such models in
addressing healthcare disparities.12,18,19 However, little is known about the specific effect
of disease management programs on disparate trends and particularly on their ability to
provide unbiased care and to improve patient outcomes equally across priority groups.
Results of a successful primary care–delivered algorithm-based diabetes disease
management program (DDMP) have been previously reported.16 Evaluation of this program
within a randomized controlled trial demonstrated significant improvements in A1C level,
blood pressure, aspirin use, patient satisfaction, and other measures.16 The program was
also found to require modest labor inputs.16,20,21 In the present study, we performed a
subanalysis of this program to examine the relationships among patient characteristics, labor
inputs, and improvement in A1C level, with a particular focus on evaluating the potential
usefulness of programs such as this to influence the care and outcomes for patients
considered to be within an AHRQ-defined priority group and for patients with less education
or no private insurance.
METHODS
We performed a randomized controlled trial of a DDMP among 217 patients with type 2
diabetes mellitus and poor glucose control (A1C level ≥8%) in an academic primary care
practice. Details of the trial have been previously published.16,20,21 Patients in the
intervention group received care from their primary care provider supplemented by a
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DDMP. The program included intensive management from clinical pharmacists and from a
diabetes care coordinator who provided diabetes education, applied algorithms for treating
glucose level abnormalities and decreasing cardiovascular risk, used an electronic registry to
proactively identify patients in need of additional care, and addressed barriers to care.
Treatment algorithms provided guidance on when to contact patients and information about
titration or addition of new medications for glucose control and cardiovascular risk
reduction. Control patients received a one-time disease management session from
pharmacists, followed by usual care from their primary care provider. The primary outcome
was improvement in A1C level over 12 months. The study was performed and subsequently
analyzed with approval from the University of North Carolina at Chapel Hill and Vanderbilt
University institutional review boards. Written consent was obtained from all study
participants.
To estimate resources required for the DDMP, the study team documented process measures
for all intervention patients. These “labor inputs” included the following: (1) minutes spent
by the disease management team in direct contact with a patient or in activities related to
patient care, (2) number of contacts with a patient, and (3) number of patient-specific
glucose medication titrations or additions. These measures captured the labor of the DDMP
and did not include any actions taken by the patient’s primary care providers.
Take-Away Points
Incorporation of a diabetes disease management program (DDMP) into the primary care
setting can aid in addressing diabetes care disparities, reflecting the nondiscriminatory
nature of algorithm-based care.
• Agency for Healthcare Research and Quality–defined priority populations
experience worse quality and access to care than their respective reference
groups.
• Little is known about the ability of DDMPs to deliver unbiased care.
• Our DDMP demonstrated significant reduction in glycosylated hemoglobin
(A1C) level among participants regardless of race/ethnicity, sex, education, or
insurance status.
• Labor inputs were similar regardless of age, race/ethnicity, sex, education, or
whether goal A1C level was achieved.
All analyses were performed using commercially available statistical software (Stata 8.0;
StataCorp LP, College Station, TX), and a 2-sided significance level of 5% was used for
statistical inference. Baseline differences between intervention and control groups were
determined using Wilcoxon rank sum test for continuous outcome variables and χ2 test for
categorical outcome variables. We examined the relationship between patient characteristics
and improvement in the median A1C level using multivariate quantile regression analysis.
Quantile regression modeling was chosen for this subanalysis because we report the median
changes for each outcome of interest. The median reporting was required because of
additional data stratification and subsequent changes in sample sizes. This should be
contrasted with how the program was evaluated in previous publications.16,21 For each
patient characteristic (age, race/ethnicity, sex, education, income, and insurance status), we
performed a separate model that included the study status, the patient characteristic in
question, and an interaction term to evaluate the potential modifying effect of intervention
status and the patient characteristic in question on change in A1C level. Patient
characteristics were dichotomized based on priority criteria of the 2007 National Healthcare
Disparities Report5 (with age dichotomized at 65 years [older adults], race/ethnicity as white
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vs nonwhite, and household annual income at $10,000). Education was dichotomized at less
than high school and insurance as private versus nonprivate. We used Wilcoxon rank sum
test to examine the relationship between each of the labor inputs (median time spent with
patients, median number of actions or contacts with patients, or median number of glucose
medication additions or titrations) and each of the aforementioned patient characteristics.
We also used Wilcoxon rank sum test to analyze the relationship between each of 3 labor
inputs and attainment of goal A1C level (≤7%) at 12 months of follow-up. Finally, we
examined the relationship between each of 3 labor inputs and improvement in the median
A1C level using multivariate quantile regression models for each labor input, with each
model adjusting for the aforementioned patient characteristics.
RESULTS
From February 2001 to April 2002, 217 patients were enrolled. Complete follow-up data
were available for 193 patients (88.9%) at 12 months. Baseline demographics revealed
diversity, with substantial sociodemographically vulnerable participants having poor
diabetes control. Most nonwhite participants were African American. Intervention and
control patients generally had similar characteristics (Table 1). The A1C levels improved
significantly more for intervention than control patients during the trial (Figure). From
baseline to 12 months, control patients had a median 1.2% decrease in A1C level, whereas
intervention patients had a median 2.1% decrease (difference, 0.9%; 95% confidence
interval, 0.6%–1.3%; P = .007).
There was no significant difference in improvement in the median A1C level when stratified
by age, race/ethnicity, sex, income, or insurance status (Figure and Table 2). There was
slightly greater improvement in the median A1C level among women compared with men
(−1.2% vs −0.5%) and among those with less than a high school education compared with
those with at least a high school education (−1.1% vs −0.8%). Results of multivariate
quantile regression analysis did not reveal any significant interaction effect on improvement
in A1C level between participants’ intervention status and each of the respective patient
characteristics of interest.
Among intervention patients, there were no differences in labor inputs (median time spent
with patients, median number of actions or contacts with patients, or median number of
glucose medication titrations or additions) when stratified by age, race/ethnicity, sex, or
education (Table 3). The disease management team had significantly more contacts and
spent more time with patients having a household annual income less than $10,000 or no
private insurance. There were no observed differences in each of 3 labor inputs when
stratified by patients obtaining the goal A1C level of 7% or less at the end of the trial. In
multivariate analysis, there was no significant relationship between each of 3 labor inputs
and improvement in the median A1C level when adjusted for age, race/ethnicity, sex,
education, income, and insurance status.
DISCUSSION
In this subanalysis of our DDMP, a successful reduction in blood glucose (A1C) level was
achieved irrespective of race/ethnicity and other important sociodemographic factors. Our
findings were not influenced by the observed differences at baseline in terms of age and
insurance status between the control and intervention groups. Also, none of the priority
sociodemographic factors analyzed had a significant modifying effect with DDMP
participation on improvement in A1C level. The time spent by the disease management team
for intervention patients was provided similarly regardless of age, race/ethnicity, sex, or
education. Improvement in A1C level did not require additional labor inputs compared with
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patients who did not show significant improvement when adjusted for patient characteristics.
Our findings suggest that DDMPs may serve as a tool for providing equal quality of care
and for addressing the current disparate trends in care often experienced by many of the
AHRQ priority groups with diabetes.
The etiology of racial/ethnic and other socioeconomic disparities in diabetes and other
chronic illness care is likely multifactorial. Disparities in provider behavior may be an
important component. Sequist and colleagues22 recently conducted a provocative study in
which they reported on variations in diabetes-related outcomes at the level of individual
physicians. They examined a 14-site primary care group practice that used an integrated
electronic medical record system and found significant within-physician variation between
the percentages of white and black patients who were able to achieve recommended levels
of glycemic, blood pressure, and lipid control. Patient sociodemographic factors accounted
for a relative range of 13% to 38% of the observed racial/ethnic differences, whereas within-
physician effects (ie, racial/ethnic disparities observed within the same physician panel)
accounted for 68% to 75% of the observed differences. A study by Schulman and
colleagues23 that surveyed 720 physicians eliciting recommendations regarding cardiac
catheterization found that sex and race/ethnicity independently influenced how physicians
managed their patients, with many physicians surveyed being less likely to recommend
needed catheterizations among women or nonwhite patients.
One reason for the success of our program in improving care regardless of socioeconomic
status may be the ability of disease management to eliminate potential disparities in
provider-level behavior. The nondiscriminatory nature of providing algorithm-based care
may serve as a means by which health systems could ensure delivery of effective and
unbiased care, while accounting for and addressing the frequent special needs that arise
when caring for traditionally vulnerable patient populations. As we observed in our
program, this could be achieved through management practices that allowed for patient-
centered approaches to care as individualized needs become evident (described herein). The
use of a team approach to care with midlevel providers and a care coordinator working
together with primary care physicians may also help to prevent provider-level disparities.
Our disease management team spent slightly more time among patients with lower income
or no private insurance. This additional time may have been related to addressing economic
barriers to attaining medications and other clinical care. More research is needed to better
understand the resources required to achieve successful outcomes across all priority groups.
In the present analysis, we also found that women and participants with less education
showed slightly greater benefit from the intervention. Greater improvement in glycemic
control among patients with less education and among women is more likely to reflect
differences by intervention status rather than by education or sex. This was supported by the
absence of an interaction effect between these variables and patient status with A1C level
and should be contrasted with the previously reported analysis showing that patients having
lower literacy had significantly more improvement in glucose control compared with those
having higher literacy.20 Significant improvement in glycemic control based on literacy
level may have been related to the fact that our intervention included several approaches to
address literacy, including the use of simplified communication, the “teach back technique”
for confirming patient understanding, lower-literacy materials, and a care coordinator who
confronted many social barriers.20 An approach in which individualized physician care of
patients with diabetes is supplemented with an adequately tailored and focused chronic
DDMP may be an important approach in eliminating disparate trends.
Several limitations were inherent in our study. Our sample size was small, and we may have
lacked adequate power to detect differences based on patient characteristics alone. In
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addition, our documented labor inputs characterize time spent with patients by the disease
management team and do not include time spent by primary care providers or the patients or
utilization of clinical services or other resources. Furthermore, the time spent by the
management team included some actions that were considered “outside” of the algorithm,
such as discussion of certain medication changes with providers. As previously reported,21
discussion with providers was required for 112 of 500 drug titrations and for 233 of 348 new
drug additions. The time required by such actions would be difficult to predict if our
program was repeated. The generalizability of our findings is also reduced by the fact that
our study was conducted at a single-site academic institution and did not have adequate
representation of several racial/ethnic minorities such as Latinos. Furthermore, our
participants at entry had poorly controlled diabetes, and it is arguable that the magnitude of
our findings would be lessened if repeated in a population with better baseline control.
Finally, although we believe that the algorithm-based care was a major factor contributing to
the balanced improvement in A1C level across the priority groups, it remains a possibility
that our findings were influenced by regression toward the mean or by the fact that our study
did not find many clinically significant racial/ethnic disparities on baseline evaluation of our
study population. One may argue that, if such disparities were in fact observed, our results
may have differed in their magnitude. There may be other factors associated with the
intervention that could have contributed to the similar improvements. For example, we
focused on patient self-management skills and provided assistance with obtaining
medications. These efforts combined with aggressive treatment using algorithm-based care
might have had synergistic effects among certain individuals.
We do not go so far as to suggest that our program has eliminated racial/ethnic disparities
but are confident that none were created among participants who received our intervention.
A disease management program integrated into primary care can be a successful model for
improving care among vulnerable patients with significant barriers. Emphasis on algorithm-
based treatment and on team approaches to care can result in improvements regardless of
race/ethnicity, sex, education, or other characteristics and represents an important tool for
addressing healthcare disparities. Future research about the role of disease management to
address health disparities in diabetes and other chronic illnesses is clearly indicated.
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Improvement in Glycosylated Hemoglobin (A1C) Level Stratified by Intervention Status
and by Race/Ethnicity
Int indicates intervention; W, white; NW, nonwhite.
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Table 1
Baseline Patient Characteristics
Characteristic Control (n = 105) Intervention (n = 112)
Age, median (IQR), y 58 (50–64) 53 (45–61)a
Older adult ≥65 y, No. (%) 21 (20.0) 17 (15.2)
Nonwhite race/ethnicity, No. (%) 63 (60.0) 81 (72.3)
Female sex, No. (%) 59 (56.2) 63 (56.3)
Household annual income <$10,000, No. (%) 54 (51.4) 47 (42.0)
<High school education, No. (%) 46 (43.8) 40 (35.7)
No private insurance, No. (%) 77 (73.3)a 66 (58.9)
Covered by Medicaid or Medicare, No. (%) 50 (47.6) 43 (38.4)
Baseline glycosylated hemoglobin level, median (IQR), % 10.1 (9.1–11.5) 10.5 (9.1–12.2)
Duration of diabetes, median (IQR), y 6 (1.25–12.50) 5 (1.63–11.00)
Presence of neuropathy, No. (%) 43 (41.0) 41 (36.6)
Use of insulin at enrollment, No. (%) 40 (38.1) 45 (40.2)
IQR indicates interquartile range.
a
P <.05 (P ≥ .05 for all other comparisons).
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Table 2
Median Change in Glycosylated Hemoglobin (A1C) Level From Baseline to 12 Months
Variable





  Older adult ≥65 y −1.2 (n = 20) −1.7 (n = 16)
  Non–older adult −1.2 (n = 75) −2.2 (n = 82)
Race/ethnicity .1 .89
  White −1.3 (n = 34) −2.1 (n = 27)
  Nonwhite −1.2 (n = 61) −2.1 (n = 71)
Sex .049 .32
  Female −1.0 (n = 54) −2.2 (n = 57)
  Male −1.5 (n = 41) −2.0 (n = 41)
Education .02 .61
  <High school −1.2 (n = 42) −2.3 (n = 34)
  ≥High school −1.2 (n = 52) −2.0 (n = 64)
Household annual income, $ .17 .62
  <10,000 −1.2 (n = 47) −1.8 (n = 41)
  ≥10,000 −1.3 (n = 46) −2.3 (n = 57)
Private insurance .08 .89
  Yes −1.8 (n = 28) −2.4 (n = 39)
  No −1.2 (n = 67) −1.9 (n = 59)
Covered by Medicaid or Medicare .06 .88
  Yes −1.2 (n = 48) −2.1 (n = 61)
  No −1.2 (n = 47) −2.2 (n = 37)
a
For difference of the 4 medians.
b
Between the variable in question and intervention status.
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